As per MRFR analysis, the US Brain Imaging Neuroimaging Market Size was estimated at 3.62 (USD Billion) in 2023. The US Brain Imaging Neuroimaging Market Industry is expected to grow from 4 (USD Billion) in 2024 to 8 (USD Billion) by 2035. The US Brain Imaging Neuroimaging Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035).
The US Brain Imaging Neuroimaging Market is experiencing significant growth due in large part to advancements in technology and increasing demand for precise diagnostic tools. Key market drivers include the rising prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis, which are prompting the need for effective imaging solutions.
Additionally, an aging population in the US is further fueling the need for comprehensive brain imaging assessments, as older adults are more susceptible to cognitive impairments. Opportunities to be explored involve the integration of artificial intelligence with neuroimaging techniques, which can enhance accuracy and efficiency in diagnosis.
Innovations in imaging modalities such as functional MRI and PET scans are creating avenues for better detection and monitoring of neurological conditions. Furthermore, the growing collaboration between academic institutions and healthcare providers is paving the way for groundbreaking research and development in brain imaging technologies.
Trends in recent times highlight a shift towards non-invasive imaging methods, with increased emphasis on patient comfort and reduced exposure to radiation. The expanding role of telemedicine in the US health system is also influencing brain imaging practices, facilitating remote consultations and assessments.
As healthcare providers seek to improve access to care, the demand for portable and user-friendly imaging devices is on the rise. Overall, the US Brain Imaging Neuroimaging Market is poised for dynamic growth, driven by technological innovation, changing demographics, and evolving healthcare needs.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The prevalence of neurological disorders is steadily increasing in the United States, creating a significant demand for brain imaging technologies. According to the Centers for Disease Control and Prevention (CDC), approximately 1 in 6 people in the US are affected by neurological diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
This alarming statistic results in more individuals seeking diagnostic neuroimaging solutions for early detection and intervention. Leading organizations, including the American Academy of Neurology, are advocating for enhanced neuroimaging capabilities to facilitate better patient outcomes.
The rise in neurological conditions has thus established a strong driver for the growth of the US Brain Imaging Neuroimaging Market Industry as healthcare providers look to implement advanced imaging techniques to improve diagnosis, aid in treatment planning, and monitor disease progression.
Rapid advancements in imaging technologies, such as Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET), are transforming the landscape of neuroimaging. The National Institute of Health (NIH) has reported a significant increase in the development of high-resolution imaging systems, which enhance the aesthetic and functional analysis of brain structures.
These innovations are supported by institutions like Siemens Healthineers and GE Healthcare, which are continuously investing in Research and Development (R&D) to enhance imaging quality and reduce examination times. The introduction of more sophisticated imaging modalities, including functional MRI and diffusion tensor imaging, is driving the US Brain Imaging Neuroimaging Market Industry forward as healthcare professionals seek to leverage these advanced tools for better patient care and improved clinical outcomes.
The aging population in the United States is projected to significantly contribute to the growth of the US Brain Imaging Neuroimaging Market Industry. By 2030, it is estimated that around 20% of the US population will be 65 years or older, according to the United States Census Bureau.
As age is a major risk factor for various neurological disorders, including dementia and stroke, the demand for neuroimaging services is expected to rise sharply in this demographic. Prominent healthcare organizations like the Alzheimer’s Association are emphasizing the necessity of neuroimaging in the care and treatment strategies for the elderly, further boosting market growth.
As healthcare systems strive to manage the implications of an aging population, innovative neuroimaging technologies will play a pivotal role in diagnosing and treating age-related neurological conditions.
The US government and private sectors are accelerating investments in healthcare infrastructure, particularly in advanced diagnostic tools such as neuroimaging technologies. The US Department of Health and Human Services allocated substantial funding towards the Improving the Health of Americans initiative which underscores the importance of enhancing healthcare services through state-of-the-art technologies.
Organizations such as the American Hospital Association report that hospitals are increasingly prioritizing investments in neuroimaging equipment to cater to the growing patient demand. As healthcare facilities upgrade their technologies and expand their capabilities, the US Brain Imaging Neuroimaging Market Industry is likely to experience accelerated growth driven by the heightened focus on advanced diagnostic solutions.
The Imaging Type segment of the US Brain Imaging Neuroimaging Market encompasses several innovative technologies that play a pivotal role in diagnosing and monitoring neurological conditions. Each imaging modality brings its unique capabilities, contributing to a comprehensive understanding of brain function and structure.
Functional Magnetic Resonance Imaging (FMRI) is particularly significant as it allows researchers and clinicians to visualize brain activity in real-time by measuring changes in blood flow, thus supporting both clinical outcomes and academic research in cognitive neuroscience. Similarly, Compound Tomography (CT) is widely recognized for its ability to quickly assess brain injuries and conditions, making it an essential tool in emergency medicine within the US healthcare system.
Positron Emission Tomography (PET) excels in detecting metabolic processes and has proven invaluable for oncology and understanding neurodegenerative diseases, further highlighting its segment's importance. Electroencephalography (EEG) provides essential insights into electrical activity in the brain, making it crucial for the assessment of epilepsy and sleep disorders, thus addressing a critical area in mental health diagnostics.
Meanwhile, Magnetoencephalography (MEG) offers high temporal resolution, allowing researchers to track brain activities with precision, which is especially useful in pre-surgical planning for epilepsy and brain tumors. Near Infrared Spectroscopy (NIRS) is gaining traction due to its non-invasive nature and applicability in monitoring brain oxygen levels in neonates and patients undergoing cognitive rehabilitation.
The diversity within the Imaging Type segment showcases ongoing advancements and drives market growth, with each modality contributing uniquely to the overall landscape of brain imaging, thus meeting the evolving demands of healthcare and research in the US. The collective strengths of these imaging techniques underline the critical need for ongoing investment in technology and innovation to improve diagnostic accuracy and patient outcomes.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The End User segment of the US Brain Imaging Neuroimaging Market encompasses various healthcare settings where neuroimaging plays a critical role in patient diagnosis and treatment. Hospitals are essential in this landscape, serving as primary facilities for advanced imaging technologies, housing specialized departments that perform MRI, CT scans, and PET scans for comprehensive patient care.
Ambulatory Surgical Centers are gaining traction due to their capacity to provide efficient surgical procedures and outpatient care, along with neuroimaging services that enhance surgical planning. Clinics also contribute significantly, often focusing on outpatient neuroimaging that caters to patients seeking diagnosis without extensive hospital stays.
Diagnostic Centers, meanwhile, are pivotal in funneling patients towards specialized imaging services, allowing for early detection and management of neurological conditions. This diverse utilization of neuroimaging across these different End Users highlights the interconnectedness of patient care and technology in the US healthcare landscape, driven by trends such as an aging population and a rising incidence of neurological disorders, further emphasizing the importance of these facilities in advancing brain imaging capabilities.
The US Brain Imaging Neuroimaging Market is characterized by rapid advancements in technology, resulting in innovative solutions that enhance diagnostic accuracy and patient outcomes. The competitive landscape is populated by several key players, each vying for market share through unique product offerings and strategic collaborations.
As the healthcare industry increasingly recognizes the importance of brain imaging in diagnosing neurological disorders and monitoring treatment efficacy, companies are focusing on developing advanced imaging technologies such as MRI, CT, and PET scans. The market is also witnessing an upsurge in partnerships between technology providers and healthcare institutions, which further drives growth and competitiveness as stakeholders aim to deliver state-of-the-art services while addressing regulatory standards and patient safety concerns.
As innovations emerge, companies that successfully harness technological advancements are likely to gain a competitive edge and strengthen their market positioning.
Toshiba Medical holds significant prominence in the US Brain Imaging Neuroimaging Market, known for its cutting-edge imaging technologies that cater to healthcare providers across the nation. The company’s strengths lie in its commitment to research and development which enables it to deliver high-resolution imaging systems that enhance diagnostic processes.
Toshiba Medical's product offerings include advanced MRI and CT systems that are recognized for their reliability and efficacy in clinical settings. The company has established a formidable market presence through strategic partnerships with renowned healthcare institutions, enriching its reputation as a trusted provider of neuroimaging solutions. Furthermore, its ability to integrate user-friendly features and innovative software solutions into its imaging technologies has fostered positive relationships with end-users, thereby solidifying its foothold in the competitive landscape.
Plexus Technology also plays a crucial role in the US Brain Imaging Neuroimaging Market, focusing on delivering specialized imaging software solutions that enhance the analysis of neuroimaging data. The company’s key products include advanced imaging analysis tools and cloud-based platforms that improve diagnostic workflows in neuroimaging.
Plexus Technology's strengths are rooted in its dedication to optimizing neuroimaging processes through innovative technology, which aids radiologists and neurologists in efficiently interpreting complex data. The company has made strategic moves through mergers and acquisitions, enabling it to expand its product portfolio and access new market avenues within the US.
This strategic positioning, combined with a focus on developing advanced algorithms for enhanced image analysis, has established Plexus Technology as a noteworthy competitor in the neuroimaging domain, empowering healthcare professionals to offer superior patient care through more informed decision-making.
Recent developments in the US Brain Imaging Neuroimaging Market indicate significant advancements and shifting dynamics. Companies like Siemens Healthineers and General Electric continue to innovate in imaging technologies, enhancing diagnostic capabilities.
In June 2023, Brain Scientific launched groundbreaking algorithms designed to improve the interpretation of neural data, showcasing the integration of AI in neuroimaging. Meanwhile, in July 2023, Medtronic disclosed plans to expand its Neurovascular product line, emphasizing the growing demand for advanced imaging solutions in medical interventions.
Notably, there were reports in August 2023 of a strategic partnership involving Elekta and Toshiba Medical to develop advanced imaging systems tailored for cancer therapy, enhancing treatment precision. In terms of market value, the US Brain Imaging Market is expected to grow substantially, driven by rising prevalence of neurological disorders.
Major players, including Philips Healthcare and Canon Medical Systems, are actively engaging in research collaborations to address these market needs. Over the past two years, the integration of artificial intelligence and deep learning models into imaging analysis has become increasingly prevalent, reflecting the industry's commitment to driving diagnostic accuracy and patient outcomes.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 3.62(USD Billion) |
| MARKET SIZE 2024 | 4.0(USD Billion) |
| MARKET SIZE 2035 | 8.0(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.504% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Toshiba Medical, Plexus Technology, Brain Scientific, AMO Pharma, Medtronic, Nervana Health, NeuroLogica Corporation, Elekta, Siemens Healthineers, Canon Medical Systems, AccuBrain, General Electric, Hitachi Medical Systems, DENSO Corporation, Philips Healthcare |
| SEGMENTS COVERED | Imaging Type, End User |
| KEY MARKET OPPORTUNITIES | Increased demand for early diagnosis, Integration of AI in imaging analysis, Advancements in imaging technologies, Rising prevalence of neurological disorders, Expansion of telemedicine services |
| KEY MARKET DYNAMICS | Technological advancements, Growing prevalence of neurological disorders, Increasing healthcare expenditure, Rising awareness and education, Aging population |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Brain Imaging Neuroimaging Market is expected to be valued at 4.0 USD Billion in 2024.
By 2035, the market is projected to reach a value of 8.0 USD Billion.
The market is anticipated to grow at a CAGR of 6.504 percent during the forecast period from 2025 to 2035.
The market is divided into Functional Magnetic Resonance Imaging, Compound Tomography, Positron Emission Tomography, Electroencephalography, and Magnetoencephalography.
Functional Magnetic Resonance Imaging (FMRI) is expected to be valued at 0.96 USD Billion in 2024.
The Compound Tomography (CT) segment is expected to grow to 1.6 USD Billion by 2035.
Major players in the market include Toshiba Medical, Siemens Healthineers, General Electric, Philips Healthcare, and Medtronic.
Electroencephalography (EEG) is expected to be valued at 0.48 USD Billion in 2024 and will grow to 0.96 USD Billion by 2035.
Advancements in technology are driving growth by enhancing imaging capabilities and increasing diagnostic accuracy in the market.
The Magnetoencephalography (MEG) segment will grow from 1.12 USD Billion in 2024 to 2.24 USD Billion by 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
